Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Screening all pregnant women for HIV would be cost effective in Britain
provided that costs are kept low and uptake high. Ades et al conducted
a cost effectiveness analysis of universal compared with selective
antenatal screening (p 1230). Their model suggests that as long as it
is worth paying £10 000 per additional life year gained, universal
antenatal HIV screening would be more cost effective than selective
testing. However in areas of low prevalence uptake must be above 90%
and test costs as low as £0.60 to allow up to 4 minutes for pretest
discussion. The study broadly supports the recent government proposal
for universal testing. However, at 50% uptake, the target set for
2000, universal testing could be less effective and more costly than a
well run selective strategy.